340B HEALTH

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2006

Legal Domicile

Principal Officer

MAUREEN TESTONI

Phone

2025525850

Tax Period

2023-01-01 to 2023-12-31

340B HEALTH, founded in 2006, is a mid-sized nonprofit in the Community Improvement sector that reported $14.3M in total revenue in fiscal year 2023. Expenses of $12.5M left a modest 12% surplus.

Mission

340B HEALTH IS A MEMBERSHIP ORGANIZATION OF MORE THAN 1,500 PUBLIC AND PRIVATE NONPROFIT HOSPITALS AND HEALTH SYSTEMS PARTICIPATING IN THE FEDERAL 340B DRUG PRICING PROGRAM. TO SUPPORT OUR MEMBERS, 340B HEALTH MONITORS, EDUCATES, AND SERVES AS...CONTINUED ON SCHEDULE OCONTINUED FROM PAGE 2...AN ADVOCATE ON FEDERAL LEGISLATIVE AND REGULATORY ISSUES RELATED TO DRUG PRICING AND OTHER MATTERS AFFECTING SAFETY-NET PROVIDERS. THE ORGANIZATION PROVIDES A WIDE VARIETY OF EDUCATION PROGRAMS AND MATERIALS TO ASSIST OUR MEMBERS IN OPERATING FULLY-COMPLIANT, HIGH-QUALITY PROGRAMS. OUR MEMBERSHIP CONSISTS OF A BROAD SPECTRUM OF PUBLIC AND NONPROFIT HOSPITALS, INCLUDING ACADEMIC MEDICAL CENTERS, COMMUNITY HOSPITALS, CHILDREN'S HOSPITALS, AND CRITICAL ACCESS HOSPITALS.

Program Service Accomplishments

Program 1

EDUCATION - 340B HEALTH HELPS HOSPITALS, HEALTH SYSTEMS, PHARMACIES, AND OTHERS UNDERSTAND THE REQUIREMENTS OF 340B AND HELP THEM COMPLY WITH ITS RULES AND REGULATIONS. 340B HEALTH PROVIDES EDUCATION THROUGH TWO ANNUAL NATIONAL CONFERENCES FOR 340B STAKEHOLDERS, WEBINARS, ROUNDTABLES WITH MEMBERS, AND ONLINE TOOLS AND RESOURCES. 340B HEALTH ALSO PROVIDES ONE-ON-ONE TECHNICAL ASSISTANCE, UPON MEMBERS' REQUESTS. 340B HEALTH KEEPS ITS MEMBERS AND STAKEHOLDERS INFORMED ABOUT NEW LEGISLATIVE AND REGULATORY CHANGES TO 340B, INCLUDING THROUGH VARIOUS ELECTRONIC COMMUNICATIONS AND THE WWW.340BHEALTH.ORG WEBSITE. 340B HEALTH ORGANIZES THE 340B COALITION'S ANNUAL WINTER AND SUMMER CONFERENCES (WWW.340BWINTERCONFERENCE.ORG AND WWW.340BSUMMERCONFERENCE.ORG)...CONTINUED ON SCHEDULE OCONTINUED FROM PAGE 2...FEATURING DISCUSSIONS ABOUT COMPLIANCE, OTHER OPERATIONAL MATTERS, PUBLIC POLICY, AND RELATED ACTIVITY. 340B HEALTH PROVIDES MEMBER HOSPITALS WITH INFORMATION TO HELP IDENTIFY BEST PRACTICES IN COMPLIANCE AND PROGRAM DEVELOPMENT. OUR "340B EXCHANGE" ALLOWS HOSPITALS TO DISCUSS EMERGING TRENDS, CONCERNS, AND IDEAS. THE ORGANIZATION'S RESEARCH HELPS IDENTIFY EXAMPLES OF HOW HOSPITALS ARE ADDRESSING KEY AREAS OF HEALTH CARE SUCH AS SOCIAL DETERMINANTS OF HEALTH AND APPROACHES TO PREVENTION OF THE MISUSE OF OPIOIDS.

Program 2

ADVOCACY - 340B HEALTH WORKS WITH AND ON BEHALF OF OUR MEMBERS TO REPRESENT THEIR INTERESTS AND CONCERNS BEFORE CONGRESS, THE EXECUTIVE BRANCH, THE COURTS, AND STATE LEGISLATURES TO ENSURE...

ADVOCACY - 340B HEALTH WORKS WITH AND ON BEHALF OF OUR MEMBERS TO REPRESENT THEIR INTERESTS AND CONCERNS BEFORE CONGRESS, THE EXECUTIVE BRANCH, THE COURTS, AND STATE LEGISLATURES TO ENSURE POLICYMAKERS UNDERSTAND THE 340B DRUG PRICING PROGRAM'S INTENT, REQUIREMENTS, VALUE, AND ROLE IN ADVANCING HEALTHY PATIENTS AND COMMUNITIES. 340B HEALTH CONDUCTS INDEPENDENT RESEARCH REGARDING THE IMPACT AND EFFECTIVENESS OF 340B AND WORKS WITH ITS MEMBERS TO CREATE PROFILES OF HOW 340B SAVINGS ARE USED TO IMPROVE PATIENT CARE. 340B HEALTH ADVOCATES FOR CHANGES IN POLICY NECESSARY TO IMPROVE 340B AND ITS IMPACT.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $392,495

Program Service Revenue $13,154,838

Investment Income $706,848

Other Revenue $600

TOTAL REVENUE $14,254,781

Expense Breakdown

Grants Paid $5,735

Salaries & Benefits $6,077,181

Fundraising Expenses $0

Other Expenses $6,395,933

TOTAL EXPENSES $12,478,849

Year-over-Year Comparison

	2023	2022	Change
Revenue	$14,254,781	$13,814,777	+0.0%
Expenses	$12,478,849	$10,968,686	+0.1%
Net Income	$1,775,932	$2,846,091	-0.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,297,141

Total Directors

Key Employees

$263,968

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
KAREN L BOWLING FACHE CFNP	CHAIR (BEG 7/23)	1.00	Officer Director	$0	$0	$0
JESSE BREIDENBACH PHARMD	DIRECTOR	1.00	Director	$0	$0	$0
BETH FELDPUSH DRPH	DIRECTOR	1.00	Director	$0	$0	$0
NICHOLAS R GNADT PHARMD	DIRECTOR	1.00	Director	$0	$0	$0
ROSLAND FISHER MCLEOD	DIRECTOR	1.00	Director	$0	$0	$0
PAUL MOLLO PHARMD	DIRECTOR	1.00	Director	$0	$0	$0
CHARLTON PARK	TREASURER	1.00	Officer Director	$0	$0	$0
MATTHEW J PERRY	SECRETARY	1.00	Officer Director	$0	$0	$0
PATRICIA K VILT	CHAIR (UNTIL 7/23)	1.00	Officer Director	$0	$0	$0
TIM LYNCH	DIRECTOR	1.00	Director	$0	$0	$0
ALI SANTORE	DIRECTOR	1.00	Director	$0	$0	$0
ONISIS STEFAS	DIRECTOR	1.00	Director	$0	$0	$0
MEETALI DESAI	DIRECTOR	1.00	Director	$0	$0	$0
SUMONA DASGUPTA	DIRECTOR	1.00	Director	$0	$0	$0
MIKE LOFTUS	DIRECTOR	1.00	Director	$0	$0	$0
ADRIAN MORAN	DIRECTOR	1.00	Director	$0	$0	$0
MAUREEN TESTONI	PRESIDENT & CEO	45.00	Officer	$847,095	$150,639	$997,734
PATRICK MCGARY	SVP OPERATIONS	45.00	Officer	$255,819	$43,588	$299,407
MICHAEL HESS	VP, OPERATIONS	45.00	Key Emp	$231,096	$32,872	$263,968
STEVEN MILLER	VP OF PHARMACY SERVICES	45.00	Highest	$271,647	$27,667	$299,314
GREGORY DOGGETT	VP LEGAL & POLICY COUNSEL	45.00	Highest	$256,079	$32,902	$288,981
CAROLINE STEINBERG	VP OF RESEARCH	45.00	Highest	$246,919	$14,661	$261,580
JOHNATHAN TILTON	SVP COMMUNICATIONS	45.00	Highest	$236,821	$7,125	$243,946
TOM O'DONNELL	SVP, GOVERNMENT RELATIONS	45.00	Highest	$350,270	$25,728	$375,998
MIRIAM LASAR	FORMER OFFICER	30.00		$203,800	$0	$203,800
CHRISTOPHER CROSSWHITE	SVP LEGAL AND POLICY	45.00		$148,352	$26,111	$174,463
KATHRYN DIBITETTO	FORMER KEY EMPLOYEE	40.00		$100,263	$0	$100,263

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$14,254,781	$12,478,849	$35,979,568	$1,775,932
2022	$13,814,777	$10,968,686	$24,919,877	$2,846,091
2022	$13,814,777	$10,968,686	$24,919,877	$2,846,091
2021	$9,750,586	$8,473,287	$25,548,585	$1,277,299
2020	$12,493,970	$8,791,305	$21,001,178	$3,702,665
2019	$11,728,558	$8,854,529	$17,756,898	$2,874,029
2018	$10,410,054	$9,905,604	$13,490,844	$504,450